123 related articles for article (PubMed ID: 35843800)
1. Big Endothelin-1 and long-term all-cause death in patients with coronary artery disease and prediabetes or diabetes after percutaneous coronary intervention.
Xu N; Zhu P; Yao Y; Jiang L; Jia S; Yuan D; Xu J; Wang H; Song Y; Gao L; Gao Z; Song L; Zhao X; Chen J; Yang Y; Xu B; Gao R; Yuan J
Nutr Metab Cardiovasc Dis; 2022 Sep; 32(9):2147-2156. PubMed ID: 35843800
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of fibrinogen in patients with coronary artery disease and prediabetes or diabetes following percutaneous coronary intervention: 5-year findings from a large cohort study.
Yuan D; Jiang P; Zhu P; Jia S; Zhang C; Liu Y; Liu R; Xu J; Tang X; Zhao X; Gao R; Yang Y; Xu B; Gao Z; Yuan J
Cardiovasc Diabetol; 2021 Jul; 20(1):143. PubMed ID: 34271936
[TBL] [Abstract][Full Text] [Related]
3. Impact of unknown diabetes and prediabetes on clinical outcomes in "nondiabetic" Chinese patients after a primary coronary intervention.
Wang H; Song Y; Tang X; Xu J; Jiang P; Jiang L; Gao Z; Chen J; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J; Gao L
Nutr Metab Cardiovasc Dis; 2020 Apr; 30(4):644-651. PubMed ID: 32143897
[TBL] [Abstract][Full Text] [Related]
4. Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes.
Jin JL; Zhang HW; Cao YX; Liu HH; Hua Q; Li YF; Zhang Y; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Li XL; Cui CJ; Liu G; Sun J; Dong Q; Santos R; Li JJ
Cardiovasc Diabetol; 2020 Sep; 19(1):152. PubMed ID: 32981521
[TBL] [Abstract][Full Text] [Related]
5. Fibrinogen is associated with glucose metabolism and cardiovascular outcomes in patients with coronary artery disease.
Liu SL; Wu NQ; Shi HW; Dong Q; Dong QT; Gao Y; Guo YL; Li JJ
Cardiovasc Diabetol; 2020 Mar; 19(1):36. PubMed ID: 32192491
[TBL] [Abstract][Full Text] [Related]
6. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
[TBL] [Abstract][Full Text] [Related]
7. The longitudinal association of remnant cholesterol with cardiovascular outcomes in patients with diabetes and pre-diabetes.
Cao YX; Zhang HW; Jin JL; Liu HH; Zhang Y; Gao Y; Guo YL; Wu NQ; Hua Q; Li YF; Li XL; Xu RX; Cui CJ; Liu G; Dong Q; Sun J; Zhu CG; Li JJ
Cardiovasc Diabetol; 2020 Jul; 19(1):104. PubMed ID: 32631321
[TBL] [Abstract][Full Text] [Related]
8. Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status.
Jin JL; Cao YX; Liu HH; Zhang HW; Guo YL; Wu NQ; Zhu CG; Xu RX; Gao Y; Sun J; Dong Q; Li JJ
Cardiovasc Diabetol; 2019 Oct; 18(1):134. PubMed ID: 31610783
[TBL] [Abstract][Full Text] [Related]
9. Prognostic value of NT-proBNP in patients with chronic coronary syndrome and normal left ventricular systolic function according to glucose status: a prospective cohort study.
Liu HH; Cao YX; Jin JL; Guo YL; Zhu CG; Wu NQ; Gao Y; Zhang Y; Xu RX; Dong Q; Li JJ
Cardiovasc Diabetol; 2021 Apr; 20(1):84. PubMed ID: 33888145
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a) and Cardiovascular Outcomes in Patients With Coronary Artery Disease and Prediabetes or Diabetes.
Jin JL; Cao YX; Zhang HW; Sun D; Hua Q; Li YF; Guo YL; Wu NQ; Zhu CG; Gao Y; Dong QT; Liu HH; Dong Q; Li JJ
Diabetes Care; 2019 Jul; 42(7):1312-1318. PubMed ID: 31076417
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes.
He J; Yang M; Song C; Zhang R; Yuan S; Li J; Dou K
J Endocrinol Invest; 2024 Apr; 47(4):883-894. PubMed ID: 37777699
[TBL] [Abstract][Full Text] [Related]
12. Prognostic utility of heart-type fatty acid-binding protein in patients with stable coronary artery disease and impaired glucose metabolism: a cohort study.
Zhang HW; Jin JL; Cao YX; Liu HH; Zhang Y; Guo YL; Wu NQ; Gao Y; Xu RX; Hua Q; Li YF; Cui CJ; Liu G; Dong Q; Sun J; Li JJ
Cardiovasc Diabetol; 2020 Feb; 19(1):15. PubMed ID: 32041617
[TBL] [Abstract][Full Text] [Related]
13. Plasma Big Endothelin-1 Levels and Long-Term Outcomes in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.
Lyu SQ; Zhu J; Wang J; Wu S; Zhang H; Shao XH; Yang YM
Front Cardiovasc Med; 2022; 9():756082. PubMed ID: 35310980
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus with mild or moderate kidney dysfunction is associated with poor prognosis in patients with coronary artery disease: A large-scale cohort study.
He J; Song C; Wang H; Zhang R; Yuan S; Dou K
Diabetes Res Clin Pract; 2023 Jun; 200():110693. PubMed ID: 37160234
[TBL] [Abstract][Full Text] [Related]
15. Plasma big endothelin-1 and stent thrombosis: An observational study in patients undergoing percutaneous coronary intervention in China.
Chen Y; Li JX; Song Y; Xu JJ; Tang XF; Jiang L; Jiang P; Liu R; Wang HH; Zhao XY; Chen J; Gao Z; Qiao SB; Gao RL; Yang YJ; Xu B; Yuan JQ
Thromb Res; 2017 Nov; 159():5-12. PubMed ID: 28942357
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
[TBL] [Abstract][Full Text] [Related]
17. Plasma big endothelin-1 levels at admission and future cardiovascular outcomes: A cohort study in patients with stable coronary artery disease.
Zhou BY; Guo YL; Wu NQ; Zhu CG; Gao Y; Qing P; Li XL; Wang Y; Dong Q; Liu G; Xu RX; Cui CJ; Sun J; Li JJ
Int J Cardiol; 2017 Mar; 230():76-79. PubMed ID: 28038820
[TBL] [Abstract][Full Text] [Related]
18. Impact of Pre-Diabetes on Coronary Plaque Composition and Clinical Outcome in Patients With Acute Coronary Syndromes: An Analysis From the PROSPECT Study.
Farhan S; Redfors B; Maehara A; McAndrew T; Ben-Yehuda O; De Bruyne B; Mehran R; Giustino G; Kirtane AJ; Serruys PW; Mintz GS; Stone GW
JACC Cardiovasc Imaging; 2019 Apr; 12(4):733-741. PubMed ID: 29055637
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of the prognostic nutritional index for patients with acute myocardial infarction undergoing percutaneous coronary intervention with variable glucose metabolism statuses: a retrospective cohort study.
Ling X; Lin C; Liu J; He Y; Yang Y; Lu N; Jie W; Liu Y; Chen S; Guo J
Diabetol Metab Syndr; 2023 Oct; 15(1):207. PubMed ID: 37875955
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous coronary intervention in diabetic versus non-diabetic patients with prior coronary artery bypass grafting: a propensity score matching study.
Ma X; Dong R; Chen P; Zhao Y; Zeng C; Xin M; Ye Q; Wang J
BMC Cardiovasc Disord; 2020 Apr; 20(1):159. PubMed ID: 32252636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
